Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021

Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021

Effectively treating hepatitis C viral (HCV) infections prevents sequelae and onward transmission. In Germany, HCV drug prescriptions have declined since 2015. During the COVID-19 pandemic, lockdowns impacted the access to HCV care services and HCV treatment. We assessed if the COVID-19 pandemic fur...

Full description

Bibliographic Details
Main Authors: Emily D. Meyer, Sandra Dudareva, Christian Kollan, Stefan Mauss, Heiner Wedemeyer, Daniel Schmidt, Ruth Zimmermann
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Public Health
Subjects:
hepatitis C
COVID-19
delivery of health care
Agenda 2030
antiviral agents - therapeutic use
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1149694/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2023.1149694/full

Similar Items